Overview
Nan Peng practices practicing medicine in Hefei, China.
Her clinical expertise encompasses Glioma, Metastatic Brain Tumor, Gliomatosis Cerebri, and Brain Tumor.
She is actively involved in clinical research, co-authoring 10 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Nan Peng
Is Nan Peng a top-rated expert for Glioma?
MediFind is an objective health platform that identifies experts based on real-world data. Nan Peng is classified as an Experienced expert for Glioma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Nan Peng participate in research or clinical trials?
Yes. Nan Peng has published 10 articles and abstracts on conditions like Glioma. You can view a list of Nan Peng's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Brain TumorMs. Peng isExperienced. Learn about Brain Tumor.
- GliomaMs. Peng isExperienced. Learn about Glioma.
- Gliomatosis CerebriMs. Peng isExperienced. Learn about Gliomatosis Cerebri.
- Lung MetastasesMs. Peng isExperienced. Learn about Lung Metastases.
- Metastatic Brain TumorMs. Peng isExperienced. Learn about Metastatic Brain Tumor.